September 15, 2026

Martinez retires after 15 years with Liphatech, including 11 years as CEO; Dillon brings broad leadership experience and deep knowledge of the organization to her new role

MILWAUKEE (September 15, 2026)—Liphatech Inc., a leading provider of rodent control solutions and a De Sangosse Group (DSG) company, today announced the retirement of CEO Manny Martinez following 15 years of service to the company, including the past 11 years as CEO. Jennifer Dillon has been named Martinez’s successor and assumed the role of CEO effective September 1, 2026, the beginning of Liphatech’s 2027 fiscal year.

“On behalf of DSG, I would like to sincerely thank Manny Martinez for his outstanding leadership, dedication and contribution to Liphatech over the past 15 years,” said Nicolas Fillon, CEO of De Sangosse Group. “Under his leadership as CEO for the past 11 years, Liphatech successfully transformed itself into the leading rodenticide company in the United States, one of DSG Group’s most strategic markets worldwide. This achievement is the result of a clear vision, strong execution, and the commitment of the entire Liphatech team. We are grateful to Manny for the lasting impact he has had on the business, its people and its future. Manny leaves behind a stronger, more competitive and better-positioned organization, providing an excellent foundation for the next stage of growth under Jennifer’s leadership.”

Under Martinez’s leadership, Liphatech strengthened its position within the U.S. rodent control market through a combination of strategic vision, disciplined execution and the commitment of its employees. His tenure helped establish a strong foundation for the company’s continued growth under Dillon’s leadership.

Dillon has worked closely alongside Martinez for many years and has progressively expanded her responsibilities across Liphatech in preparation for the leadership transition.

Throughout her 12-year tenure with the company, Dillon has developed extensive knowledge of Liphatech’s people, operations, processes and strategic priorities. Her leadership experience spans Human Resources, Quality, Information Technology, Safety, Regulatory Affairs, Research and Development, Customer Service and Graphics, as well as more recent responsibilities involving Operations and Production.

Dillon also has gained significant exposure to Liphatech’s commercial, marketing and financial management activities, providing her with a comprehensive understanding of the organization and its customers.

“Jennifer’s appointment reflects our commitment to continuity, stability and developing talented leaders from within our businesses,” Fillon said. “She knows Liphatech exceptionally well, is highly respected throughout the organization and brings a broad understanding of the business to her new position. We are confident she is the right leader to build upon the strong foundation Manny and the Liphatech team have established and guided the company through its next phase of development.”

The leadership transition also reflects De Sangosse Group’s philosophy that sustainable growth is built upon strong local leadership, deep market knowledge, entrepreneurial spirit and the continued development of talent throughout its businesses.

“We sincerely thank Manny for everything he has contributed to Liphatech and De Sangosse Group and wish him the very best in retirement,” Fillon added. “At the same time, we congratulate Jennifer on her appointment and look forward to supporting her as Liphatech continues its growth and leadership journey in the years ahead.”